Enveric Biosciences, Inc.
ENVB· Nasdaq
ENVBEnveric Biosciences, Inc.
Quarterly figures for Enveric Biosciences, Inc., with source filings when available.
61 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Enveric Biosciences, Inc. has filed its 10-Q within 43 to 45 days of period end across its last 8 quarters. The 10-K runs 85 to 91 days.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 · after-hours | Aug 14, 2026 | 45 d | 10-Q | — | — | -$0.76 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 15, 2026 · pre-market |
| May 15, 2026 |
| 45 d |
| 10-Q |
| — |
| — |
| -$1.08 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 27, 2026 · after-hours | Mar 27, 2026 | 86 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 · after-hours | Nov 14, 2025 | 45 d | 10-Q | — | — | -$10.81 | |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 · pre-market | Aug 14, 2025 | 45 d | 10-Q | — | — | -$11.65 | |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | — | — | -$14.58 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Mar 28, 2025 | 87 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | — | — | -$43.10 | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · after-hours | Aug 12, 2024 | 43 d | 10-Q | — | — | -$3.72 | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 15, 2024 | 45 d | 10-Q | — | — | -$9.21 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 26, 2024 · pre-market | Mar 26, 2024 | 86 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | — | — | -$1.30 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 11, 2023 | 42 d | 10-Q | — | — | -$3.04 | |
| Q1 2023 | Mar 31, 2023 | Apr 3, 2023 · after-hours | May 15, 2023 | 45 d | 10-Q | — | — | -$2.31 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$1.46 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | — | — | -$2.73 | |
| Q1 2022 | Mar 31, 2022 | Apr 1, 2022 · market hours | May 13, 2022 | 43 d | 10-Q | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | — | — | -$0.12 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | — | — | -$0.04 | |
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | — | — | -$0.20 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Apr 1, 2021 | 91 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 16, 2020 | 47 d | 10-Q | $8.48M | −7.3% | -$0.20 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | $8.25M | −25.1% | -$0.48 | |
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | $9.60M | −10.1% | -$0.60 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 25, 2020 | 85 d | 10-K | $9.06M | −11.9% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 8, 2019 | 39 d | 10-Q | $9.15M | −13.5% | -$0.03 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | $11.02M | −0.5% | -$0.67 | |
| Q1 2019 | Mar 31, 2019 | — | May 14, 2019 | 44 d | 10-Q | $10.69M | −3.4% | -$1.09 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 26, 2019 | 85 d | 10-K | $10.28M | −10.2% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | $10.58M | −15.6% | $0.16 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $11.08M | −9.7% | -$0.07 | |
| Q1 2018 | Mar 31, 2018 | — | May 15, 2018 | 45 d | 10-Q | $11.06M | −10.4% | -$0.11 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Apr 2, 2018 | 92 d | 10-K | $11.45M | −7.5% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 13, 2017 | 44 d | 10-Q | $12.53M | +24.6% | -$0.31 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 14, 2017 | 45 d | 10-Q | $12.27M | +83.5% | -$0.26 | |
| Q1 2017 | Mar 31, 2017 | — | May 12, 2017 | 42 d | 10-Q | $12.34M | +76.0% | -$0.09 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Mar 31, 2017 | 90 d | 10-K | $12.39M | +63.4% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $10.06M | +125.4% | -$0.13 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 12, 2016 | 43 d | 10-Q | $6.69M | — | -$0.09 | |
| Q1 2016 | Mar 31, 2016 | — | May 16, 2016 | 46 d | 10-Q | $7.01M | — | -$0.09 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | — | — | — | $7.58M | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 23, 2015 | 54 d | 10-Q | $4.46M | — | -$0.02 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | — | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 13, 2014 | 44 d | 10-Q | — | — | $0.00 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Mar 28, 2014 | 87 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 6, 2013 | 37 d | 10-Q | — | — | $0.00 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 1, 2013 | 32 d | 10-Q | — | — | $0.00 | |
| Q1 2013 | Mar 31, 2013 | — | May 2, 2013 | 32 d | 10-Q | — | — | $0.00 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Feb 28, 2013 | 59 d | 10-K | — | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 13, 2012 | 44 d | 10-Q | — | — | $0.00 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 1, 2012 | 32 d | 10-Q | — | — | $0.00 | |
| Q1 2012 | Mar 31, 2012 | — | May 3, 2012 | 33 d | 10-Q | — | — | $0.00 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Mar 7, 2012 | 67 d | 10-K | — | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | 45 d | 10-Q | — | — | $0.00 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 2, 2011 | 33 d | 10-Q | — | — | $0.00 | |
| Q1 2011 | Mar 31, 2011 | — | May 16, 2011 | 46 d | 10-Q | — | — | $0.00 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 7, 2011 | 66 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 15, 2010 | 46 d | 10-Q | — | — | $0.00 | |
| Q2 2010 | Jun 30, 2010 | — | Aug 13, 2010 | 44 d | 10-Q | — | — | $0.00 | |
